EFFECT OF ETHANOL-WATER COMPOSITION ON CLINDAMYCIN HYDROCHLORIDE PSEUDOPOLYMORPHISM
DOI:
https://doi.org/10.22159/ijpps.2016v8i11.14132Keywords:
Clindamycin HCl, Hydrate, Ethanolate, StabilityAbstract
Objective: Formation of clindamycin hydrochloride (clindamycin HCl) in monohydrate-ethanolate from the recrystallization process with ethanol–water (5:2) has been reported a long time ago. However, the effect of ethanol-water compositions into pseudo-polymorphism formation and its stability of was not reported yet. This study aimed to investigate the effect of ethanol-water proportion on the formation of clindamycin HCl-monohydrate and its ethanol solvate.
Methods: Clindamycin HCl was recrystallized with the various percentages of ethanol. The fresh and after storage for 24 h at humidity and room temperature (25±2 °C, RH: 70±1%) crystals were characterized by FTIR (Fourier transform infra-red), PXRD (powder x-ray diffractometer), and DTA (differential scanning calorimeter). The study of desolvation/dehydration then was observed with a polarization microscopy-plate heater.
Results: The results showed that monohydrate crystal was obtained from recrystallization in a concentration less than 50% ethanol in water. Next, the ethanolate was produced from the solvent of>70% ethanol. Meanwhile, the 50–70 % ethanol produced a hydrate–ethanolate, crystal, which has both hydrate and ethanol in its lattice. This hydrate-ethanolates was unstable, even in ambient temperature.
Conclusion: Concentration of ethanol in water as the solvent will determine the clindamycin HCl pseudo polymorphism, which will back to its original crystal form by the time of storage.
Downloads
References
Storey AR, Ymen I. Solid state characterization of pharmaceutics. 1st ed. United Kingdom: John Wiley and Sons, LTD; 2011. p. 23.
Brittain HG. Polymorphism in pharmaceutical solids. 2nd ed. New York: Informa Healthcare USA Inc; 2009. p. 233-6.
Vippagunta SR, Brittain HG, Grant DJW. Crystalline solids. Adv Drug Delivery Rev 2001;48:3-26.
Babra RS, Christopher PP, Adivaraha J, Adam JM, Nair RH. General principles of solid pharmaceutical polymorphs: a supramolecular perpective. Adv Drug Delivery Rev 2004;56:241-74.
Thompson C. investigating the fundamentals of drug crystal growth using atomic force microscopy. Thesis Magister, The University of Nottingham, England; 2003. p. 18, 27.
Thanusubramanian H, Chogtu B, Magazine R. Adverse reaction due to clindamycin. Asian J Pharm Clin Res 2016;9:8-9.
Lund W. The pharmaceutical codex. 12thed. The Pharmaceutical Press: London; 1994. p. 41-43, 808-11.
Sweetman SC. Martindale: the complete drug reference. 36th ed. London: Pharmaceutical Press; 2009. p. 251-3.
Ravikumar K, Sridhar B. Clindamycin hydrochloride and its ethanol solvate. Acta Crystallogr Sect C: Struct Chem 2010; 66:97-100.
Beckstead HD, Neville GA, Shurvell HF. Differentiation of solvated spirolactone samples by FT-Raman and FT-IR diffuse reflectance spectroscopy. Fresenius’s J Anal Chem 1993; 11:727-32.
Nugrahani I, Ibrahim S, Mauludin R, Almira M.
Hydrate transformation study of fluoroquinolone antibiotics using Fourier transform infrared spectroscopy (FTIR). Int J Pram Pharm 2015;7:246–52.
Villers MM, Mahlatji MD. The physical transformation of niclosamide solvate in pharmaceutical suspensions determined by DSC and TG analysist. Pharmazie 2004;59:534-40.
Junyavraperst VB, Morakul B. Nanocrystals for enhancement of oral bioavailability of poorly water-soluble drugs. Asian J Pharm Sci 2015;10:13-23.
Keshwani B, Jaimini M, Sharma D. Spherical crystallisation: a revolution in the field of particle engineering. Int J Curr Pharm Res 2015;7:19-25.
Dixit M. Preparation and characterization of spray dried microparticle and chilled spray dried particle of ketoprofen by spray drying method. Asian J Pharm Clin Res 2011;4:138-42.
Nugrahani I, Pertiwi EA, Putra OD. Theophylline–na–saccharine single crystal isolation for its structure determination. Int J Pharm Pharm 2015;7:15–24.
Published
How to Cite
Issue
Section
